News and Announcements
OncoSil Medical Appoints New CFO
- Published October 22, 2015 1:07PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd October 2015, ASX Announcement
OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce the appointment of Mr Tom Milicevic as Chief Financial Officer and Company Secretary, effective from 22 October 2015.
Mr Milicevic is a vastly experienced commercial, financial and management accountant with more than 20 years’ experience in a career which includes a number of major Australian and international public companies.
He has specific financial expertise in medical device and biotech companies and his appointment represents a pivotal hire for the Company as it transitions from a development focus to the commercialisation of its OncoSilTM localised radiation treatment for cancer.
To read the full announcement, please click here.